Paul L. Prather

4.7k total citations
96 papers, 3.8k citations indexed

About

Paul L. Prather is a scholar working on Cellular and Molecular Neuroscience, Pharmacology and Molecular Biology. According to data from OpenAlex, Paul L. Prather has authored 96 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Cellular and Molecular Neuroscience, 54 papers in Pharmacology and 38 papers in Molecular Biology. Recurrent topics in Paul L. Prather's work include Cannabis and Cannabinoid Research (50 papers), Receptor Mechanisms and Signaling (26 papers) and Neuropeptides and Animal Physiology (24 papers). Paul L. Prather is often cited by papers focused on Cannabis and Cannabinoid Research (50 papers), Receptor Mechanisms and Signaling (26 papers) and Neuropeptides and Animal Physiology (24 papers). Paul L. Prather collaborates with scholars based in United States, South Korea and Japan. Paul L. Prather's co-authors include Lisa K. Brents, Jeffery H. Moran, William E. Fantegrossi, Anna Radomińska‐Pandya, Ping‐Yee Law, Kathryn A. Seely, Jing‐Gen Liu, Horace H. Loh, Lirit N. Franks and Harbans Lal and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Paul L. Prather

95 papers receiving 3.7k citations

Peers

Paul L. Prather

PHARM

CMN

TOXIC

Matteo Marti Italy

William E. Fantegrossi United States

Giovanna La Rana Italy

Andrea Tontini Italy

Dow P. Hurst United States

Michael Bayewitch Israel

Dana E. Selley United States

James J. Burston United Kingdom

Josée Guindon United States

Raj K. Razdan United States

Matteo Marti Italy

Paul L. Prather

686 ×0.3

PHARM

2.8k ×1.4

CMN

914 ×0.7

TOXIC

1.5k ×1.2

390 ×1.0

Citations per year, relative to Paul L. Prather Paul L. Prather (= 1×) peers Matteo Marti

Countries citing papers authored by Paul L. Prather

Since Specialization

Citations

This map shows the geographic impact of Paul L. Prather's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul L. Prather with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul L. Prather more than expected).

Fields of papers citing papers by Paul L. Prather

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul L. Prather. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul L. Prather. The network helps show where Paul L. Prather may publish in the future.

Co-authorship network of co-authors of Paul L. Prather

This figure shows the co-authorship network connecting the top 25 collaborators of Paul L. Prather. A scholar is included among the top collaborators of Paul L. Prather based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul L. Prather. Paul L. Prather is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Zeyuan, William E. Fantegrossi, Swati Nagar, et al.. (2022). Similar 5F-APINACA Metabolism between CD-1 Mouse and Human Liver Microsomes Involves Different P450 Cytochromes. Metabolites. 12(8). 773–773. 1 indexed citations

Mu, Shengyu, et al.. (2022). Non-Canonical Cannabinoid Receptors with Distinct Binding and Signaling Properties in Prostate and Other Cancer Cell Types Mediate Cell Death. International Journal of Molecular Sciences. 23(6). 3049–3049. 1 indexed citations

Fantegrossi, William E., et al.. (2022). Metabolites of Synthetic Cannabinoid 5F-MDMB-PINACA Retain Affinity, Act as High Efficacy Agonists and Exhibit Atypical Pharmacodynamic Properties at CB1 Receptors. Toxicological Sciences. 187(1). 175–185. 6 indexed citations

Penthala, Narsimha Reddy, et al.. (2020). 7-Azaindolequinuclidinones (7-AIQD): A novel class of cannabinoid 1 (CB1) and cannabinoid 2 (CB2) receptor ligands. Bioorganic & Medicinal Chemistry Letters. 30(22). 127501–127501. 5 indexed citations

Fantegrossi, William E., et al.. (2019). Enzymatic analysis of glucuronidation of synthetic cannabinoid 1-naphthyl 1-(4-fluorobenzyl)-1H-indole-3-carboxylate (FDU-PB-22). Xenobiotica. 49(12). 1388–1395. 3 indexed citations

Ford, Benjamin M., Sherrica Tai, Lirit N. Franks, et al.. (2019). Reduced Tolerance and Asymmetrical Crosstolerance to Effects of the Indole Quinuclidinone Analog PNR-4-20, a G Protein–Biased Cannabinoid 1 Receptor Agonist in Mice: Comparisons with Δ9-Tetrahydrocannabinol and JWH-018. Journal of Pharmacology and Experimental Therapeutics. 369(2). 259–269. 5 indexed citations

Prather, Paul L., et al.. (2017). Preclinical assessment of utility of M6S for multimodal acute and chronic pain treatment in diabetic neuropathy. Life Sciences. 192. 151–159. 7 indexed citations

Ford, Benjamin M., Amit Ketkar, Robert L. Eoff, et al.. (2016). Antinociceptive effects of the 6- O -sulfate ester of morphine in normal and diabetic rats: Comparative role of mu- and delta-opioid receptors. Pharmacological Research. 113(Pt A). 335–347. 17 indexed citations

Ford, Benjamin M., et al.. (2015). (434) Analgesic profile of morphine 6-O-sulfate sodium: a mixed mu/delta agonist in the treatment of diabetic neuropathic pain. Journal of Pain. 16(4). S84–S84. 1 indexed citations

10.

Brents, Lisa K., et al.. (2013). Differential Drug–Drug Interactions of the Synthetic Cannabinoids JWH-018 and JWH-073: Implications for Drug Abuse Liability and Pain Therapy. Journal of Pharmacology and Experimental Therapeutics. 346(3). 350–361. 45 indexed citations

11.

Prather, Paul L., et al.. (2013). CB1 and CB2 receptors are novel molecular targets for Tamoxifen and 4OH-Tamoxifen. Biochemical and Biophysical Research Communications. 441(2). 339–343. 23 indexed citations

12.

Seely, Kathryn A., Lisa K. Brents, Lirit N. Franks, et al.. (2012). AM-251 and rimonabant act as direct antagonists at mu-opioid receptors: Implications for opioid/cannabinoid interaction studies. Neuropharmacology. 63(5). 905–915. 82 indexed citations

13.

Chimalakonda, Krishna C., Kathryn A. Seely, Stacie M. Bratton, et al.. (2012). Cytochrome P450-Mediated Oxidative Metabolism of Abused Synthetic Cannabinoids Found in K2/Spice: Identification of Novel Cannabinoid Receptor Ligands. Drug Metabolism and Disposition. 40(11). 2174–2184. 163 indexed citations

14.

Ju, Chung, Sun‐Young Hwang, Geum-Sil Cho, et al.. (2012). Differential anti-ischemic efficacy and therapeutic time window of trans- and cis-hinokiresinols: Stereo-specific antioxidant and anti-inflammatory activities. Neuropharmacology. 67. 465–475. 8 indexed citations

15.

Mayeux, Philip R., et al.. (2005). Agonist-Directed Trafficking of Response by Endocannabinoids Acting at CB2 Receptors. Journal of Pharmacology and Experimental Therapeutics. 315(2). 828–838. 107 indexed citations

16.

Liu, Jing‐Gen & Paul L. Prather. (2002). Chronic Agonist Treatment Converts Antagonists into Inverse Agonists at δ-Opioid Receptors. Journal of Pharmacology and Experimental Therapeutics. 302(3). 1070–1079. 28 indexed citations

17.

Liu, Jing‐Gen & Paul L. Prather. (2001). Chronic Exposure to μ-Opioid Agonists Produces Constitutive Activation of μ-Opioid Receptors in Direct Proportion to the Efficacy of the Agonist Used for Pretreatment. Molecular Pharmacology. 60(1). 53–62. 84 indexed citations

18.

Prather, Paul L., et al.. (1995). Ca2+ channel and adenylyl cyclase modulation by cloned mu-opioid receptors in GH3 cells.. Molecular Pharmacology. 47(5). 1041–1049. 79 indexed citations

19.

Prather, Paul L., et al.. (1995). Properties of a κ-opioid receptor expressed in CHO cells: interaction with multiple G-proteins is not specific for any individual Gα subunit and is similar to that of other opioid receptors. Molecular Brain Research. 29(2). 336–346. 57 indexed citations

20.

Lai, H. & Paul L. Prather. (1990). Protracted ethanol withdrawal in rats: Tolerance to the anxiolytic effects of diazepam and pentobarbital but not phenobarbital. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact